Search research articles
Contact Us
Filters
Showing results (61-70 of 88) with videos related to
Page
of 9
Sort By:
Psychopharmacology
|
January 1, 1995
Strain differences in the rewarding and dopamine-releasing effects of morphine in rats
M Shoaib, R Spanagel, T Stohr, et al.
Pharmacology, Biochemistry, and Behavior
|
January 1, 1989
Morphine-induced place conditioning is not confounded by drug-induced alterations in locomotor activity
T S Shippenberg, M W Emmett-Oglesby, A Herz
The European Journal of Neuroscience
|
July 21, 2009
Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms
V I Chefer, L Denoroy, A Zapata, et al.
Psychopharmacology
|
January 1, 1991
Beta-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens
R Spanagel, A Herz, R Bals-Kubik, et al.
Journal of Neurochemistry
|
March 29, 2000
Modulation of the neurotoxic effects of methamphetamine by the selective kappa-opioid receptor agonist U69593
E El Daly, V Chefer, S Sandill, et al.
Arzneimittel-Forschung
|
February 1, 1992
[Opiate addiction. Pharmacologic and biochemical aspects]
A Herz, T S Shippenberg, R Bals-Kubik, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1993
Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats
R Bals-Kubik, A Ableitner, A Herz, et al.
Neuroreport
|
July 17, 1998
Infusion of a D-1 receptor agonist into the nucleus accumbens enhances cocaine-induced behavioural sensitization
T J De Vries, A R Cools, T S Shippenberg
Psychopharmacology
|
June 1, 1994
Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release
R Spanagel, O F Almeida, C Bartl, et al.
Synapse (New York, N.Y.)
|
October 17, 1998
Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist
C A Heidbreder, S Schenk, B Partridge, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 88) with videos related to
Sort By:
Page
of 9
Psychopharmacology
|
January 1, 1995
Strain differences in the rewarding and dopamine-releasing effects of morphine in rats
M Shoaib, R Spanagel, T Stohr, et al.
Pharmacology, Biochemistry, and Behavior
|
January 1, 1989
Morphine-induced place conditioning is not confounded by drug-induced alterations in locomotor activity
T S Shippenberg, M W Emmett-Oglesby, A Herz
The European Journal of Neuroscience
|
July 21, 2009
Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms
V I Chefer, L Denoroy, A Zapata, et al.
Psychopharmacology
|
January 1, 1991
Beta-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens
R Spanagel, A Herz, R Bals-Kubik, et al.
Journal of Neurochemistry
|
March 29, 2000
Modulation of the neurotoxic effects of methamphetamine by the selective kappa-opioid receptor agonist U69593
E El Daly, V Chefer, S Sandill, et al.
Arzneimittel-Forschung
|
February 1, 1992
[Opiate addiction. Pharmacologic and biochemical aspects]
A Herz, T S Shippenberg, R Bals-Kubik, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1993
Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats
R Bals-Kubik, A Ableitner, A Herz, et al.
Neuroreport
|
July 17, 1998
Infusion of a D-1 receptor agonist into the nucleus accumbens enhances cocaine-induced behavioural sensitization
T J De Vries, A R Cools, T S Shippenberg
Psychopharmacology
|
June 1, 1994
Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release
R Spanagel, O F Almeida, C Bartl, et al.
Synapse (New York, N.Y.)
|
October 17, 1998
Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist
C A Heidbreder, S Schenk, B Partridge, et al.
Page
of 9